Sandu Pharmaceuticals Limited (524703) fair value: what the stock is really worth
As of Nov 17, 2026: fair value (intrinsic value) of Sandu Pharmaceuticals Limited stock ₹54.87, price ₹36.55, upside +50.1%, quality 71 out of 100. Rating: strongly undervalued. Calculated from audited financials with 25 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Sandu Pharmaceuticals Limited
524703 · BSECheap (33% below fair value) and solid company, but falling price: meets 2 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 16, 2026.
How to read this chart
60‑month range ₹30.52 – ₹77.82 · fair‑value band ₹41.15 – ₹68.59 · the ₹36.55 price screens below the ₹54.87 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 16, 2026.
Every Wednesday you see whether Sandu Pharmaceuticals is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Sandu Pharmaceuticals Limited manufactures and markets ayurvedic medicines under the SANDU brand in India and internationally. The company offers medicines in the areas of cardiovascular, endocrine, digestive, genito-urinary, muscular-skeletal, nervous, male reproductive, and respiratory system.
Show moreShow less
It also provides medicines for gynecological; nutrition; skin; and ear, nose, and throat disorders. The company was founded in 1899 and is based in Mumbai, India.
Stock analysis
Sandu Pharmaceuticals Limited (524703) currently trades at ₹36.55, while our model-based Fair Value estimate is ₹54.87, implying the stock looks roughly 33% undervalued today.
Show more
Valuation
Bull case: the Growth DCF group reads highest at a median of ₹78.82 per share, and 19 of the 25 models we run sit above the ₹36.55 price.
Bear case: the Asset-Based group reads lowest at ₹18.53, and 6 of the 25 models stay below the price. Data coverage for this calculation is low.
Scenario range: ₹41.15 (bear) to ₹68.59 (bull), the price of ₹36.55 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 71/100 (solid quality), in the Health Care sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Sandu Pharmaceuticals Limited reported revenue of ₹699M in FY2026 versus ₹655M in FY2022, a compound +1.7%/yr. Reported net income was ₹17.7M in FY2026, compounding +2.7%/yr from FY2022.
Key figures
Market cap ₹353M (≈ $3.8M) Micro · P/E ratio 44.1 · P/S ratio 0.41 · EPS (TTM) ₹0.6210 · Dividend yield 3.6% · Net margin 0.9% · Return on assets (EBIT) 3.9% (5-year average) · Operating margin 1.6%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 30 out of 100 (low confidence).
What moves the price
The share trades about 21% below its 52-week high and 20% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Health Care peers we cover trades at −35% fair-value upside, at 50%, 524703 screens cheaper than that median.
Fair Value models
All 25 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Growth Forecast
Watch 524703, get fair value alerts →
Compare Sandu Pharmaceuticals Limited with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Pharmaceuticals · 58 stocks
Valuation Multiplesvs Pharmaceuticals median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Return on equity by industry
- Quality Score by industry
- PEG screener for stocks with fair value
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Pharmaceuticals stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Huons Global Co 084110 | 18,970 KRW | 47,019 KRW | +148% | vs 524703 |
| DongKook Pharmaceutical Co 086450 | 24,800 KRW | 28,372 KRW | +14% | vs 524703 |
| ST Pharm Co 237690 | 71,000 KRW | 61,182 KRW | −14% | vs 524703 |
| Vivozon Pharmaceutical Co 082800 | 2,780 KRW | 2,179 KRW | −22% | vs 524703 |
| Oscotec Inc 039200 | 32,750 KRW | 21,262 KRW | −35% | vs 524703 |
| NatureCell Co 007390 | 21,800 KRW | 11,176 KRW | −49% | vs 524703 |
| Mezzion Pharma Co 140410 | 63,800 KRW | 31,450 KRW | −51% | vs 524703 |
| BINEX Co 053030 | 6,800 KRW | 1,844 KRW | −73% | vs 524703 |
| Caregen Co 214370 | 26,850 KRW | 5,414 KRW | −80% | vs 524703 |
| SHUKRAPHAR SHUKRAPHAR | ₹82.25 | ₹9.14 | −89% | vs 524703 |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Sandu Pharmaceuticals Limited (524703) overvalued or undervalued?
What is the fair value of 524703?
What is the quality score of 524703?
What is the price target for Sandu Pharmaceuticals Limited (524703)?
What is the Sandu Pharmaceuticals Limited stock forecast for 2026?
What is the revenue of Sandu Pharmaceuticals Limited (524703)?
Does Sandu Pharmaceuticals Limited pay a dividend?
How much is the dividend of Sandu Pharmaceuticals Limited (524703)?
What growth is priced into Sandu Pharmaceuticals Limited (524703)?
What discount rate (WACC) does the fair value of 524703 use?
What is a reverse DCF?
How much growth has Sandu Pharmaceuticals Limited (524703) delivered so far?
How fast is the sector of Sandu Pharmaceuticals Limited (524703) growing?
What is the free cash flow yield of Sandu Pharmaceuticals Limited (524703)?
What is the intrinsic value of Sandu Pharmaceuticals Limited (524703)?
Is Sandu Pharmaceuticals Limited stock overvalued or undervalued in 2026?
Is fair value the same as the market price of 524703?
How much is Sandu Pharmaceuticals Limited worth?
What do the bullish and bearish scenarios say about 524703?
What is the P/E ratio of 524703?
How far is 524703 from its 52-week high?
Which stocks are comparable to Sandu Pharmaceuticals Limited?
Is Sandu Pharmaceuticals Limited stock attractive at the current price?
How is the fair value of 524703 calculated?
Is it still worth investing in stocks now?
What is the share price of Sandu Pharmaceuticals Limited (524703)?
What should I pay attention to with Sandu Pharmaceuticals Limited right now?
Key figures of Sandu Pharmaceuticals Limited
How large is the market capitalisation of Sandu Pharmaceuticals Limited (524703)?
What is the P/S ratio of Sandu Pharmaceuticals Limited (524703)?
What are the earnings per share of Sandu Pharmaceuticals Limited (524703)?
What is the dividend yield of Sandu Pharmaceuticals Limited (524703)?
What is the net margin of Sandu Pharmaceuticals Limited (524703)?
What is the EBIT return on assets of Sandu Pharmaceuticals Limited (524703)?
What is the operating margin of Sandu Pharmaceuticals Limited (524703)?
How fast is revenue growing at Sandu Pharmaceuticals Limited (524703)?
How fast are earnings growing at Sandu Pharmaceuticals Limited (524703)?
How much net debt does Sandu Pharmaceuticals Limited (524703) carry?
Watch Sandu Pharmaceuticals Limited in the live analysis
One click puts Sandu Pharmaceuticals Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.